Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study

2013243 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 383, Issue 9922, pp. 1049-1058

Field-Weighted Citation Impact: 28.67